Evidence map›Paper›PMID 35842687›Full record

ArticleEuropean journal of medical research2022

Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration.

Ashish Kothari, Shyam Kishor Kumar, Vanya Singh, Prashant Kumar, Karanvir Kaushal, Atul Pandey, Neeraj Jain, Balram Ji Omar

Open access · goldAbstract read
In one paragraph

Article in European journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen ofPharmaceuticals (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ashish KothariDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, 249203, India.
Shyam Kishor KumarDepartment of Microbiology, All India Institute of Medical Sciences, Deoghar, 814152, India.
Vanya SinghDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, 249203, India.
Prashant KumarDepartment of Biochemistry, All India Institute of Medical Sciences, Rishikesh, 249203, India.
Karanvir KaushalDepartment of Biochemistry, All India Institute of Medical Sciences, Rishikesh, 249203, India.
Atul PandeyDepartment of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI, 48109, USA.
Neeraj JainDepartment of Medical Oncology, All India Institute of Medical Sciences, Rishikesh, 249203, India. neeraj.monc@aiimsrishikesh.edu.in.
Balram Ji OmarDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, 249203, India. balram.micro@aiimsrishikesh.edu.in.
All India Institute of Medical Sciences RishikeshAll India Institute of Medical Sciences, DeogharUniversity of Michigan–Ann Arbor · US

Funding

AIIMS, Rishikesh 319/IEC/Ph.D./2018
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an adaptable bacterial pathogen that infects a variety of organs, including the respiratory tract, vascular system, urinary tract, and central nervous system, causing significant morbidity and mortality. As the primary goal of this study, we wanted to determine how pigment color production differed between clinical strains of P. aeruginosa, and whether or not that variation was associated with multidrug resistance or the ability to form biofilms. We screened in total 30.1% of yellow, 39.8% green and 30.1% of no pigment-producing P. aeruginosa strains from a total of 143 various clinical isolates. Yellow pigment-producing strains presented significant resistance to antibiotics groups, including β-lactam (91.5%), aminoglycosides (70.5%), and carbapenems (51.9%) compared to green and non-pigmented strains. Notably, 16.3% of yellow pigment-producing strains were resistant to colistin which is used as a last-resort treatment for multidrug-resistant bacteria, whereas only 2.3% of non-pigmented and 1.8% of green pigmented strains were resistant to colistin. Aside from that, yellow pigment-producing strains were frequent producers of enzymes belonging to the lactamase family, including ESBL (55.6%), MBL (55.6%), and AmpC (50%). Compared to the green groups (7.14%) and non-pigmented groups (28.5%), they had a higher frequency of efflux positive groups (64.2%). Notably, when compared to non-pigmented groups, green pigment-producing strains also displayed antibiotic susceptibility behavior similar to yellow pigment-producing strains. The majority of yellow pigment-producing strains outperformed the green and non-pigmented strains in terms of MIC levels when compared to the other two groups of strains. Despite the fact that previous studies have demonstrated a direct correlation between multidrug resistance behaviors and biofilm production, no such statistically significant association between pigment and biofilm formation was found in our investigation. Our research has demonstrated that the correlation of bacterial pigments on their susceptibility to antimicrobial agents. Yellow pigment-producing P. aeruginosa strains posed a significant problem due to the lack of alternative agents against such transformed strains, which may be associated with the development of multidrug resistance.

Indexed as

Pseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial Agentsbeta-LactamasesColistinDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesColistinBiofilmDrug effluxMinimal inhibitory concentrationMultidrug resistancePigment productionβ-Lactamase

Identifiers

PMID35842687
PMCPMC9288039
OpenAlexW4285586997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.